ImmunoPrecise Antibodies Receivables 2022-2024 | IPA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

ImmunoPrecise Antibodies receivables from 2022 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

ImmunoPrecise Antibodies receivables from 2022 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$9.3B
Hims & Hers Health (HIMS)	$6.7B
Inspire Medical Systems (INSP)	$5.7B
Enovis (ENOV)	$2.7B
IRhythm Technologies (IRTC)	$2.6B
Privia Health (PRVA)	$2.6B
Azenta (AZTA)	$2.2B
Omnicell (OMCL)	$2.1B
10x Genomics (TXG)	$1.8B
Clover Health Investments (CLOV)	$1.7B
Schrodinger (SDGR)	$1.6B
Phreesia (PHR)	$1.2B
Butterfly Network (BFLY)	$673M
Standard BioTools (LAB)	$637M
Talkspace (TALK)	$559M
Fulgent Genetics (FLGT)	$547M
Definitive Healthcare (DH)	$541M
Health Catalyst (HCAT)	$517M
Pulmonx (LUNG)	$255M
TruBridge (TBRG)	$253M
SOPHiA GENETICS SA (SOPH)	$212M
American Well (AMWL)	$138M
EUDA Health Holdings (EUDA)	$108M
P3 Health Partners (PIII)	$85M
HeartBeam (BEAT)	$75M
111 (YI)	$53M
CareCloud (CCLD)	$50M
Outset Medical (OM)	$46M
Zepp Health (ZEPP)	$45M
SHL Telemedicine (SHLT)	$42M